• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿加曲班联合 tPA 导管溶栓治疗髂股腘静脉血栓形成。

Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis.

机构信息

Arizona Cardiovascular Consultants, 3850 E Baseline Road, Bldg1, Suite 102, Mesa, AZ, 85206, USA.

A. T. Still University, 5850 East Still Circle, Mesa, AZ, 85206, USA.

出版信息

Cardiovasc Intervent Radiol. 2013 Dec;36(6):1586-1590. doi: 10.1007/s00270-013-0569-3. Epub 2013 Feb 2.

DOI:10.1007/s00270-013-0569-3
PMID:23377239
Abstract

PURPOSE

Catheter-directed thrombolysis (CDT) is a highly effective approach in the treatment of deep venous thrombosis (DVT). There are no data on the primary use of CDT with argatroban and tissue plasminogen activator (tPA) in patients without heparin-induced thrombocytopenia (HIT). The aim of this study was to evaluate the efficacy and safety of the combined administration of argatroban and tPA during CDT for massive DVT in patients without HIT.

METHODS

Thirty-three patients with massive symptomatic iliac and femoropopliteal DVT underwent CDT with tPA and argatroban within 28 ± 6 h of presentation. The dose of tPA was 0.75-1 mg/h through the infusion port and that of argatroban at 0.3-1 μg/kg/min through the side port of the sheath. The patients were evaluated for the efficacy and safety of CDT and recurrent symptomatic venous thromboembolism (VTE) at a mean follow-up of 22 months.

RESULTS

There was no bleeding or iatrogenic pulmonary embolism with the CDT regimen we used. Grade III lysis (complete resolution of thrombus on venography) was achieved in 30 patients (91 %). In 3 patients with additional inferior vena cava filter thrombosis, further thrombectomy of the filter was required. No patient developed recurrent VTE.

CONCLUSION

Concomitant administration of argatroban and tPA is a highly safe and effective regimen for CDT for massive DVT.

摘要

目的

导管溶栓(CDT)是治疗深静脉血栓形成(DVT)的一种非常有效的方法。目前尚无关于在无肝素诱导血小板减少症(HIT)的患者中,使用阿加曲班和组织型纤溶酶原激活剂(tPA)进行首次 CDT 的数据。本研究旨在评估在无 HIT 的大量 DVT 患者中,联合使用阿加曲班和 tPA 进行 CDT 的疗效和安全性。

方法

33 例有症状的髂股和腘静脉血栓形成的大量患者在发病后 28 ± 6 小时内行 CDT 治疗,同时使用 tPA 和阿加曲班。tPA 的剂量为 0.75-1mg/h 通过输注端口,阿加曲班的剂量为 0.3-1μg/kg/min 通过鞘的侧端口。在平均 22 个月的随访中,评估 CDT 和复发性有症状静脉血栓栓塞症(VTE)的疗效和安全性。

结果

我们使用的 CDT 方案没有出血或医源性肺栓塞。30 例患者(91%)达到了 3 级溶解(静脉造影完全清除血栓)。在 3 例伴有额外下腔静脉滤器血栓形成的患者中,需要进一步进行滤器血栓切除术。没有患者发生复发性 VTE。

结论

阿加曲班和 tPA 同时给药是治疗大量 DVT 的 CDT 的一种安全有效的方案。

相似文献

1
Catheter-directed thrombolysis with argatroban and tPA for massive iliac and femoropopliteal vein thrombosis.阿加曲班联合 tPA 导管溶栓治疗髂股腘静脉血栓形成。
Cardiovasc Intervent Radiol. 2013 Dec;36(6):1586-1590. doi: 10.1007/s00270-013-0569-3. Epub 2013 Feb 2.
2
Evaluation of thrombolysis using tissue plasminogen activator in lower extremity deep venous thrombosis with concomitant femoral-popliteal venous segment involvement.下肢深静脉血栓形成伴股腘静脉段受累患者应用组织型纤溶酶原激活物溶栓的评估。
J Vasc Surg Venous Lymphat Disord. 2017 Sep;5(5):613-620. doi: 10.1016/j.jvsv.2017.04.018. Epub 2017 Jun 21.
3
Catheter-directed thrombolysis for the management of postpartum deep venous thrombosis.导管定向溶栓治疗产后深静脉血栓形成
Acta Obstet Gynecol Scand. 2005 Feb;84(2):155-8. doi: 10.1111/j.0001-6349.2005.00565.x.
4
Catheter-directed Venous Thrombolysis in acute iliofemoral vein thrombosis--the CaVenT study: rationale and design of a multicenter, randomized, controlled, clinical trial (NCT00251771).急性髂股静脉血栓形成的导管定向静脉溶栓治疗——CaVenT研究:一项多中心、随机、对照临床试验的原理与设计(NCT00251771)
Am Heart J. 2007 Nov;154(5):808-14. doi: 10.1016/j.ahj.2007.07.010. Epub 2007 Sep 6.
5
Inflow thrombosis does not adversely affect thrombolysis outcomes of symptomatic iliofemoral deep vein thrombosis.症状性髂股深静脉血栓形成的流入性血栓并不影响溶栓治疗的效果。
J Vasc Surg. 2011 Aug;54(2):448-53. doi: 10.1016/j.jvs.2011.02.033. Epub 2011 May 28.
6
Use of argatroban and catheter-directed thrombolysis with alteplase in an oncology patient with heparin-induced thrombocytopenia with thrombosis.在一名患有肝素诱导的血小板减少症并伴有血栓形成的肿瘤患者中使用阿加曲班和导管定向溶栓联合阿替普酶治疗。
Am J Health Syst Pharm. 2014 May 1;71(9):711-6. doi: 10.2146/ajhp130132.
7
Acute iliofemoral venous thrombosis in patients with atresia of the inferior vena cava can be treated successfully with catheter-directed thrombolysis.对于下腔静脉闭锁患者合并髂股静脉急性血栓形成,采用导管定向溶栓治疗可获得满意的疗效。
J Vasc Interv Radiol. 2011 Jun;22(6):801-5. doi: 10.1016/j.jvir.2011.01.449. Epub 2011 Apr 2.
8
Catheter-directed thrombolysis and stenting in the treatment of iliac vein compression syndrome with acute iliofemoral deep vein thrombosis: outcome and follow-up.导管定向溶栓和支架置入术治疗伴有急性髂股深静脉血栓形成的髂静脉压迫综合征:结果与随访
Ann Vasc Surg. 2014 May;28(4):957-63. doi: 10.1016/j.avsg.2013.11.012. Epub 2014 Jan 16.
9
Posterior tibial vein approach to catheter-directed thrombolysis for iliofemoral deep venous thrombosis.经胫后静脉入路导管直接溶栓治疗髂股型深静脉血栓形成。
J Vasc Surg Venous Lymphat Disord. 2019 Sep;7(5):629-634. doi: 10.1016/j.jvsv.2019.01.064. Epub 2019 Jun 21.
10
Intermittent pneumatic compression of the foot and calf improves the outcome of catheter-directed thrombolysis using low-dose urokinase in patients with acute proximal venous thrombosis of the leg.对足部和小腿进行间歇性气动压迫可改善使用低剂量尿激酶进行导管定向溶栓治疗急性近端下肢静脉血栓形成患者的疗效。
J Vasc Surg. 2005 Nov;42(5):940-4. doi: 10.1016/j.jvs.2005.07.041.

引用本文的文献

1
Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19.新型冠状病毒肺炎血栓形成事件预防与治疗的治疗考量
Thromb Update. 2023 Mar;10:100126. doi: 10.1016/j.tru.2022.100126. Epub 2022 Nov 11.
2
Catheter-Based Therapies and Other Management Strategies for Deep Vein Thrombosis and Post-Thrombotic Syndrome.基于导管的深静脉血栓形成和血栓后综合征治疗及其他管理策略
J Clin Med. 2020 May 12;9(5):1439. doi: 10.3390/jcm9051439.
3
Catheter-directed thrombolysis for patients with acute lower extremity deep vein thrombosis: a meta-analysis.
急性下肢深静脉血栓形成患者的导管定向溶栓治疗:一项荟萃分析
Rev Lat Am Enfermagem. 2018 Jun 21;26:e2990. doi: 10.1590/1518-8345.2309.2990.
4
Catheter-Directed Thrombolysis Versus Standard Anticoagulation for Acute Lower Extremity Deep Vein Thrombosis: A Meta-Analysis of Clinical Trials.导管定向溶栓与标准抗凝治疗急性下肢深静脉血栓形成:临床试验的荟萃分析
Clin Appl Thromb Hemost. 2018 Oct;24(7):1134-1143. doi: 10.1177/1076029617739703. Epub 2017 Nov 13.
5
Safety of catheter-directed thrombolysis for the treatment of acute lower extremity deep vein thrombosis: A systematic review and meta-analysis.导管定向溶栓治疗急性下肢深静脉血栓形成的安全性:一项系统评价和荟萃分析。
Medicine (Baltimore). 2017 Sep;96(35):e7922. doi: 10.1097/MD.0000000000007922.
6
Co-ordinated spatial propagation of blood plasma clotting and fibrinolytic fronts.血浆凝血和纤维蛋白溶解前沿的协调空间传播。
PLoS One. 2017 Jul 7;12(7):e0180668. doi: 10.1371/journal.pone.0180668. eCollection 2017.
7
The management of filter-related caval thrombosis complicated by heparin-induced thrombocytopenia and thrombosis.滤器相关的腔静脉血栓形成合并肝素诱导的血小板减少症和血栓形成的管理。
Int J Clin Exp Med. 2015 Aug 15;8(8):13078-88. eCollection 2015.